Literature DB >> 26710889

The role of ubiquitin-specific protease 14 (USP14) in cell adhesion-mediated drug resistance (CAM-DR) of multiple myeloma cells.

Xiaohong Xu1, Jing Liu2, Chaoyan Shen2, Linlin Ding2, Fei Zhong2, Yu Ouyang2, Yuchan Wang2, Song He1.   

Abstract

OBJECTIVE: Cell adhesion-mediated drug resistance (CAM-DR) is one of the mechanisms underlying the drug resistance in multiple myeloma (MM). Ubiquitin-specific protease 14 (USP14) is downregulated in the apoptotic model and upregulated in the adhesive model of MM. This study was undertaken to determine the role of USP14 in CAM-DR of MM cells.
METHODS: We examined the expression of USP14 in the apoptotic model of MM. The mechanism of USP14 in the process of apoptosis was further explored by flow cytometry assay and co-immunoprecipitation. We then performed the cell co-culture and adhesion assay and cell viability assay to investigate the effect of USP14 on adhesive rate and drug resistance in MM.
RESULTS: We discovered that USP14 played a negative role in cell apoptosis, which is correlated with Bcl-xl. Moreover, overexpression of USP14 in MM cell adhesion model could enhance the ability of cell adhesion by regulating Wnt-signaling pathways, thereby promoting the CAM-DR in MM.
CONCLUSION: USP14 participates in CAM-DR of MM through acting as a bridge between Bcl-xl apoptotic pathway and Wnt-signaling pathways and may be represented as a good candidate for pursuing clinical trials in MM.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Multiple myeloma; Ubiquitin-specific protease 14; apoptosis; cell adhesion-mediated drug resistance

Mesh:

Substances:

Year:  2016        PMID: 26710889     DOI: 10.1111/ejh.12729

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  14 in total

1.  BTK induces CAM-DR through regulation of CXCR4 degradation in multiple myeloma.

Authors:  Wang Wang; Rongfang Wei; Shijia Liu; Li Qiao; Jianhao Hou; Chunyan Gu; Ye Yang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 2.  The role of deubiquitinating enzymes in cancer drug resistance.

Authors:  Parthasaradhireddy Tanguturi; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Cancer Chemother Pharmacol       Date:  2020-03-07       Impact factor: 3.333

Review 3.  Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents.

Authors:  Xin Chen; Qianqian Yang; Lu Xiao; Daolin Tang; Q Ping Dou; Jinbao Liu
Journal:  Cancer Metastasis Rev       Date:  2017-12       Impact factor: 9.264

Review 4.  The Role of Deubiquitinating Enzymes in Hematopoiesis and Hematological Malignancies.

Authors:  Neha Sarodaya; Janardhan Karapurkar; Kye-Seong Kim; Seok-Ho Hong; Suresh Ramakrishna
Journal:  Cancers (Basel)       Date:  2020-04-28       Impact factor: 6.639

5.  Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN.

Authors:  Bin Liu; Shangwen Jiang; Min Li; Xuelian Xiong; Mingrui Zhu; Duanzhuo Li; Lei Zhao; Lili Qian; Linhui Zhai; Jing Li; Han Lu; Shengnan Sun; Jiandie Lin; Yan Lu; Xiaoying Li; Minjia Tan
Journal:  Nat Commun       Date:  2018-11-13       Impact factor: 14.919

6.  Chinese Herbal Medicine Wenxia Changfu Formula Reverses Cell Adhesion-Mediated Drug Resistance via the Integrin β1-PI3K-AKT Pathway in Lung Cancer.

Authors:  YaNan Zhang; ZhiChun Wu; HuaYun Yu; HuaXin Wang; Guowei Liu; ShiJun Wang; XuMing Ji
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

Review 7.  Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential.

Authors:  Jun-Nan Guo; Bai-Rong Xia; Shen-Hui Deng; Chang Yang; Ya-Nan Pi; Bin-Bin Cui; Wei-Lin Jin
Journal:  Front Cell Dev Biol       Date:  2021-06-09

Review 8.  Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis.

Authors:  Ishita Gupta; Kanika Singh; Nishant K Varshney; Sameena Khan
Journal:  Front Cell Dev Biol       Date:  2018-02-09

9.  Knockdown of ubiquitin‑specific protease 51 attenuates cisplatin resistance in lung cancer through ubiquitination of zinc‑finger E‑box binding homeobox 1.

Authors:  Feng Zhou; Chunling Du; Donghui Xu; Jinchang Lu; Lei Zhou; Chaomin Wu; Bo Wu; Jianan Huang
Journal:  Mol Med Rep       Date:  2020-05-27       Impact factor: 2.952

10.  Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade.

Authors:  Yiwei Wang; Yuxuan Jiang; Shan Ding; Jiawang Li; Ningjing Song; Yujing Ren; Danning Hong; Cai Wu; Bin Li; Feng Wang; Wei He; Jiawei Wang; Ziqing Mei
Journal:  Cell Res       Date:  2018-09-25       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.